Announced Sat, 30 May · 20:12 IST

Reg 24A

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.7%1-day move
₹3.45
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.7-1.2-0.9-0.9-4.3-1.7+12.2+9.9
Up moveDown movePending
AI summary

Natural Biocon (India) Ltd has filed its Annual Secretarial Compliance Report for FY ended March 31, 2026, prepared by Practicing Company Secretary Rupal Patel. The report identifies multiple non-compliance issues: the company failed to publish quarterly and yearly financial results in newspapers, submitted financial results late (facing fines of ₹59,000 for March 2025 results and ₹75,000 for September 2025 results), delayed submission of the Share Capital Audit Report, and did not update its website as required under SEBI regulations. The company also received SEBI summons for production of documents before the Investigating Authority on multiple dates. Additionally, secretarial standards compliance was lacking as registers and minutes books were not updated. Management has stated they will take corrective action.

Likely market impact

This filing reveals recurring compliance failures and regulatory penalties that reflect poorly on the company's governance standards. Investors should note the repeated delays in disclosures and the ongoing SEBI investigation, which may raise concerns about operational transparency and internal controls.